Pharmaceuticals

Global Fibromyalgia Drugs Market 2015-2019

  • TEC250932
  • 73 Pages
  • July 2015
  • Pharmaceuticals
About Fibromyalgia

According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, fibromyalgia is a syndrome with an unknown cause and chronic pain and muscle tenderness as the major symptoms. Unlike arthritis, it does not cause joint, muscle or other tissue inflammation. However, fibromyalgia is known to cause impairment of joints, soft tissues, and causes significant pain and fatigue. Fibromyalgia affects women more than men. In the US, the condition affects more than 5 million people aged 18 years and above, of which 80-90% are women. There is no particular diagnostic test for detecting fibromyalgia, and physicians undertake differential diagnosis to check the presence of the syndrome. Currently in the US, only three drugs are approved to treat fibromyalgia. Off-label treatment is a popular option to treat fibromyalgia using analgesics, antidepressants, sedatives, neuroleptics, and muscle relaxants.

Technavio's analysts forecast the global fibromyalgia drugs market to grow at a CAGR of 0.79% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global fibromyalgia drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of fibromyalgia.

Based on the chemical class of the drugs used to treat fibromyalgia, the market is segmented as follows:

Serotonin norepinephrine reuptake inhibitors
GABA analogs
Others

Technavio's report, the Global Fibromyalgia Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

This report includes a discussion of the market in the following three regions:

Americas: The major countries here are the US, Canada, Mexico, and Brazil
EMEA: The major countries here are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
APAC: The major countries here are Japan, China, Australia, Singapore, South Korea, and India.

APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.

Key Regions
Americas
APAC
EMEA

Key Vendors
Actavis
Eli Lilly
Pfizer

Other Prominent Vendors
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Merck Sharp and Dohme
Switch Biotech
Theravance
Tonix
Zynerba Pharmaceuticals


Key Market Driver
Unmet Medical Needs
For a full, detailed list, view our report

Key Market Challenge
Adverse Events
For a full, detailed list, view our report

Key Market Trend
Expected Entry of ""Me-too"" Drugs
For a full, detailed list, view our report

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Pharmaceutical Excipients Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

Over the Counter (OTC) & Diet Supplementary Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of ...

March 2017  |   Price:$ 7695    | Pre Book Price:$ 7695

Read More >>

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>